Fig. 3
From: Stemness-related LncRNA pair signature for predicting therapy response in gastric cancer
IC50 values for cytotoxic chemotherapeutics between different risk stratifications. A-D The IC50 values of 4 cytotoxic chemotherapeutics acquired from pRRophetic algorithm, A cisplatin, B gemcitabine, C doxorubicin, and D vinblastine, were significantly lower in the low-risk group. E and F The IC50 values of 2 targeted drugs acquired from pRRophetic algorithm, including E pazopanib and F dasatinib, were significantly lower in the high-risk group. (Mann-Whitney U test * for p < 0.05, ** for p < 0.01, and *** for p < 0.001)